share_log

Veeva Systems | 8-K: Veeva Announces Fiscal 2025 Second Quarter Results

Veeva Systems | 8-K: Veeva Announces Fiscal 2025 Second Quarter Results

Veeva Systems | 8-K：Veeva公布2025财年第二季度业绩
美股SEC公告 ·  2024/08/28 16:08

Moomoo AI 已提取核心信息

Veeva Systems delivered strong Q2 FY2025 results with total revenues reaching $676.2M, up 15% YoY, led by subscription services revenue growth of 19% to $561.3M. Operating income increased 60% to $166.5M, while non-GAAP operating income rose 32% to $279.8M. Net income grew 53% to $171.0M with diluted EPS of $1.04.The company made significant product advances, including the release of Vault CRM Service Center and enhanced Veeva Site Connect capabilities. Veeva added 14 new Vault CRM customers and secured strategic wins, including a top 20 biopharma standardizing on Vault RIM Suite and Vault CTMS. The Clinical Database solution was selected by seven top 20 biopharmas.For Q3 FY2025, Veeva expects revenues between $682-685M and non-GAAP operating income of $273-275M. The company updated its FY2025 guidance, projecting total revenues of $2,704-2,710M and non-GAAP operating income of approximately $1,080M.
Veeva Systems delivered strong Q2 FY2025 results with total revenues reaching $676.2M, up 15% YoY, led by subscription services revenue growth of 19% to $561.3M. Operating income increased 60% to $166.5M, while non-GAAP operating income rose 32% to $279.8M. Net income grew 53% to $171.0M with diluted EPS of $1.04.The company made significant product advances, including the release of Vault CRM Service Center and enhanced Veeva Site Connect capabilities. Veeva added 14 new Vault CRM customers and secured strategic wins, including a top 20 biopharma standardizing on Vault RIM Suite and Vault CTMS. The Clinical Database solution was selected by seven top 20 biopharmas.For Q3 FY2025, Veeva expects revenues between $682-685M and non-GAAP operating income of $273-275M. The company updated its FY2025 guidance, projecting total revenues of $2,704-2,710M and non-GAAP operating income of approximately $1,080M.
Veeva Systems在2025财年第二季度交出了强劲的业绩，总营收达到67620万，同比增长15%，其中订阅服务收入增长19%，达到56130万。运营收入增长了60%，达到了16650万，而非GAAP运营收入上升32%，达到了27980万。净利润增长53%，达到了17100万，摊薄后每股收益为1.04美元。公司在产品方面取得了显著进展，包括发布了Vault CRm服务中心和增强的Veeva Site Connect功能。Veeva新增了14个Vault CRm客户，并获得了一些战略性胜利，包括一家排名前20的生物制药公司在Vault RIm Suite和Vault CTMS上进行标准化。...展开全部
Veeva Systems在2025财年第二季度交出了强劲的业绩，总营收达到67620万，同比增长15%，其中订阅服务收入增长19%，达到56130万。运营收入增长了60%，达到了16650万，而非GAAP运营收入上升32%，达到了27980万。净利润增长53%，达到了17100万，摊薄后每股收益为1.04美元。公司在产品方面取得了显著进展，包括发布了Vault CRm服务中心和增强的Veeva Site Connect功能。Veeva新增了14个Vault CRm客户，并获得了一些战略性胜利，包括一家排名前20的生物制药公司在Vault RIm Suite和Vault CTMS上进行标准化。临床数据库解决方案被七家排名前20的生物制药公司所选择。对于2025财年第三季度，Veeva预计营收将在68200万到68500万之间，非GAAP运营收入将在27300万到27500万之间。公司更新了其2025财年指引，预计总营收为270400万到271000万，非GAAP运营收入约为108000万。

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    iCoreConnect
    ICCT
    -- 1.780
    VSee Health
    VSEE
    -- 1.240
    新氧
    SY
    -- 0.949
    SHL Telemedicine
    SHLT
    -- 2.073
    HeartBeam
    BEAT
    -- 2.000
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日